Helen C. Su
ActionAid(US)National Institutes of Health(US)Innsbruck Medical University(AT)Universität Innsbruck(AT)University of Cambridge(GB)National Institute of Allergy and Infectious Diseases(US)Office of Extramural Research(US)University of Pennsylvania(US)
Publications by Year
Research Areas
Immunodeficiency and Autoimmune Disorders, Immune Cell Function and Interaction, Blood disorders and treatments, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Regulation of an ATG7 - beclin 1 Program of Autophagic Cell Death by Caspase-8(2004)1,214 cited
- → Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee(2022)1,096 cited
- → Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4(2014)828 cited
- → Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging(2007)793 cited
- → Combined Immunodeficiency Associated with DOCK8 Mutations(2009)727 cited
- → Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy(2015)668 cited